Replies to post #444621 on Amarin Corp Plc (AMRN)

[JRoon71]

And the new formulation could/would extend that.

Getting the u s market back with an extended patent life. Believe the patent expires around 2032.

[TastyTheElf]

There's a pile at 2030 and another pile at 2033. I don't know what governs.

Scanning, it looks like most of the REDUCE-IT patents are 2033.

[alm2]

Tastie
It’s all about the things which one by one will increase share price
Most important profitable every quarter from here on in with profits increasing over time then a varied list of things
New formulation will help sales even with generic competition
Hikma case may reduce generic competition/ may remove it altogether
Hikma case may produce damages
New uses for the drug in the future in cancer and other conditions
Buy backs ?
Cash position generally
Inventory
Tax losses
I am sure there are many more positive outcomes than I list
However the SP will be unlikely to skyrocket
Steady increase over next two years
Sale of the company ?
When all these are taken into account this stock will not go down in value
It can only go up
How far up and quickly are the variables
You don’t need to worry your head so rest easy -
Alm